A Plasmodiophora Brassicae Effector PbCBM1 Promotes Clubroot Susceptibility by Competitively Binding to AtPHB3 to Disrupt Salicylic Acid Biosynthesis in Plants
Plant, Cell & Environment · 2026
DOI: 10.1111/pce.70638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant, Cell & Environment, 2026. Verfasst von Jingyan Fu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Bio-Resources and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Salicylic Acid, Plasmodiophorida, Plant Diseases, Brassica napus. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, Science and Technology Program of Sichuan Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Plasmodiophora brassicae poses a severe threat to rapeseed ( Brassica napus ) production worldwide. As an obligate biotrophic pathogen, it deploys effectors to suppress host immunity, yet how these effectors manipulate plant defence, particularly salicylic acid (SA)‐b‐mediated immunity, remains largely unknown. In this study, a CBM1 (carbohydrate‐binding module)‐containing effector, PbCBM1, from P. brassicae was identified, which is secreted and suppresses INF1/BAX‐induced cell death. PbCBM1 ‐overexpressing Arabidopsis showed significantly elevated susceptibility to P. brassicae . AtPHB3 (Prohibitin 3), a key regulator of SA biosynthesis, was identified as the interactor of PbCBM1 both in vivo and in vitro. The phb3 mutant also exhibited increased susceptibility, suggesting that PbCBM1 may promote plant susceptibility by targeting AtPHB3 during pathogen infection. The subsequent results showed that PbCBM1 ‐overexpressing plants reduced SA pathway gene expression and isochorismate/SA accumulation upon chitin treatment. Furthermore, LUC and competitive Co‐IP assays revealed that PbCBM1 competes with AtICS1 (Isochorismate synthase 1) for AtPHB3 binding. Collectively, P. brassicae secretes the effector PbCBM1 to competitively target AtPHB3, disrupting AtPHB3‐AtICS1 complex integrity, thereby suppressing SA biosynthesis and immunity. This study reveals a novel molecular mechanism by which a biotrophic pathogen subverts plant defence and provides potential targets for breeding clubroot‐resistant rapeseed varieties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Bio-Resources and Eco-Environment, College of Life Sciences, Sichuan University, Chengdu, China.
- Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Rui Wang
Förderung
- National Key Research and Development Program of China
- Science and Technology Program of Sichuan Province
- Fundamental Research Funds for the Central Universities
- National Basic Research Program of China
Zitieren
APA
Fu, J., Zhu, R., Li, X., Liu, X., Li, Y., Wu, S., Yang, H., Yang, S., Niu, Q., Wang, M., & Wang, R. (2026). A Plasmodiophora Brassicae Effector PbCBM1 Promotes Clubroot Susceptibility by Competitively Binding to AtPHB3 to Disrupt Salicylic Acid Biosynthesis in Plants. Plant, Cell & Environment. https://doi.org/10.1111/pce.70638
Vancouver
Fu J, Zhu R, Li X, Liu X, Li Y, Wu S, et al. A Plasmodiophora Brassicae Effector PbCBM1 Promotes Clubroot Susceptibility by Competitively Binding to AtPHB3 to Disrupt Salicylic Acid Biosynthesis in Plants. Plant, Cell & Environment. 2026. doi:10.1111/pce.70638
BibTeX
@article{Fu2026,
author = {Fu, Jingyan and Zhu, Ruijia and Li, Xinmeng and Liu, Xiaoqun and Li, Yanlin and Wu, Shifan and Yang, Haiyi and Yang, Siyu and Niu, Qian and Wang, Maolin and Wang, Rui},
title = {A Plasmodiophora Brassicae Effector PbCBM1 Promotes Clubroot Susceptibility by Competitively Binding to AtPHB3 to Disrupt Salicylic Acid Biosynthesis in Plants},
journal = {Plant, Cell & Environment},
year = {2026},
doi = {10.1111/pce.70638}
}
EUVIMED